This study explores the usage of T cell antigen receptor (TCR) ~ chain elements in Lewis rats with experimentally induced allergic encephalomyelitis (EAE). TCRs from 15 different T cell clones and hybridomas derived from animals immunized with myelin basic protein (MBP), and all having specificity for the 21-mer encephalitogenic fragment MBP 68-88, utilized V~8.2. In addition, there was a marked conservation of the first two amino acid residues of the junctional complementarity determining region 3 (CDR3) associated with the V~8.2 receptors. 12 of 15 contained an aspartic acid followed by serine regardless of the associated JB element. At the nudeotide level, this conservation of AspSer residues was accomplished with few or no nongermlineencoded nucleotide (N) additions. A similar pattern of AspSer usage and N region nucleotide additions was observed in a number of V~8.2 isolates derived from MBP-immunized lymph nodes. In contrast, VB8.2 polymerase chain reaction amplified isolates from Lewis T cells activated with concanavalin A or from lymph nodes of complete Freund's adjuvant-immunized animals showed no AspSer utilization (0/31) in the CDR3, and four to nine N region nudeotide additions. We conclude from this finding that AspSer residues in the CDR3, limited N region nucleotide additions, along with V~8.2 sequences, contribute to TCR specificity for MBP 68-88. This raises the possibility that encephalitogenic, disease-causing T cells either represent a population that derives from late fetal life or alternatively, that they are rare cells with this particular TCR phenotype contributed to the T cell pool throughout adulthood and are selected by antigen. In either case, the CDR3 AspSer sequences as well as V~8.2 sequences are candidates for the receptor target structures recognized by regulator T cells in recovery from and resistance to active EAE. In this respect, a preliminary analysis of TCR utilization in three T cell clones specific for MBP 68-88 isolated from animals recovered from active EAE indicates that while all three use V~8.2, only one contains AspSer in the CDR3.
N
'early all T cell immune responses involve the recognition by ot/3 heterodimeric TCR of antigen that has been processed and represented on the surface of APC as peptides bound to MHC molecules (1) . TCR ot and 3 chains are each derived from multiple germline-encoded elements which undergo somatic recombination during T cell development. In the mouse, the repertoire of ot chain germline genes is thought to number approximately 100 different variable (Vot) segments and also 100 different joining (Jot) elements. TCK/~ chains are derived from a repertoire of gene segments which has been estimated to consist of 25 different VB elements, 12 JB genes, and two diversity (D/~) elements.
Random joining of these various intra ot and ~ chain elements plus combinatory associations of different ot and B chains permit a considerable degree of TCR diversity. In addition, during the somatic process of V/J recombination (WD/J for /~ chains), further diversity is created in the junctional regions through the addition of nongermline encoded nucleotides (N region). Given the number of different germline elements, the number of possible junctional region sequences, and the combinatory associations of the two chains, it has been estimated that the potential TCR repertoire is of the order 1015-1022 specificities (2, 3) .
Theoretical modeling of the interaction between TCR. mol-ecules and peptide/MHC complexes has suggested that certain regions encoded within Vo~ and VB, corresponding to the CDR1 and CDR2 of Ig, interact with ol helices of the MHC molecule, and recognition of the MHC-associated peptide occurs primarily via the (N)JoL and (N)Dfl(N)Jfl elements comprising the CDR3 of the two chains (2, 4) . Despite the very large number of possible TCR specificities, a number of studies have shown that the major portion of the T cell response to a number of different protein antigens is directed to a few immunodominant epitopes within the protein molecule. In addition, TCR utilization in these responses, even to a single immunodominant epitope, is often quite limited (5) (6) (7) (8) (9) (10) . An example of such a pauciclonal response, dominated by a single or a few TCR ol/fl chain combinations, was first demonstrated to be the case for pigeon cytochrome c in H-2 ' mice (5).
Another example of limited TCR utilization occurs in the immune response of rats immunized with guinea pig myelin basic protein (MBP) 1 to induce experimental allergic encephalomyelitis (EAE), a paralytic, T cell-mediated demyelinating autoimmune disease that is widely studied as an animal model for multiple sclerosis in humans (11) . Here, the T cell response of Lewis rats is directed primarily to an immunodominant epitope contained within the encephalitogenic amino acid 68-88 fragment of the MBP molecule (MBP 68-88). This T cell response is also highly restricted, dominated by T cells that use Vfl8 almost exclusively and Vot2 frequently (12) .
This finding of conserved Vc~ and Vfl utilization in EAE raises the possibility that CDR3 junctional regions might also be utilized in a limited way since these are believed to be involved in recognition of the peptide in the MHC groove. Here we report TCR fl chain sequences of numerous T cell clones and hybridomas reactive to MBP 68-88. All utilized the Vf18.2 segment. But in addition, these sequence comparisons reveal a marked dominance (12/15) of AspSer in the first two amino acid positions associated with multiple Jfl elements, and few or no N region nucleotide additions in the CDR3 region. Receptor utilization in lymph nodes taken directly from MBP-immunized rats showed a similar pattern not seen in adjuvant-immunized control animals. CDR3 sequences of Vf18.2 + control populations activated with Con A or derived from CFA-immune donors showed no such utilization of AspSer sequences and many more N region nucleotide additions.
Materials and Methods
Animals. 8-12-wk-old female Lewis (LEW) rats were purchased from Harlan Sprague Dawley Inc. (Indianapolis, IN) .
Isolation of T Cell Clones. The origins of all T cell clones used in this study have been previously described (13, 14) . Briefly, cells were obtained from the draining lymph nodes of animals undergoing active EAE as a consequence of immunization 2 wk earlier 1 Abbreviations used in this paper: EAE, allergic encephalomyelitis; LEW, Lewis rats; MBP, myelin basic protein; TdT, terminal deoxytransferase.
with 50/~g of guinea pig MBP emulsified in CFA containing 400 I~g MFobacterium tuberculosis strain H37Ra (Difco Laboratories, Inc., Detroit, MI). Lymphocyte suspensions were cultured briefly with antigen and T cell clones were derived in soft agar (13) . Lymphocytes were also obtained from the primary draining lymph nodes of animals immediately after recovery from active disease and T cell clones were established by limiting dilution (14) . All clones derived from animals undergoing active disease, and two of the three clones from recovered animals assessed in this study have been shown previously to be encephalitogenic in adoptive transfer experiments (13, 14) .
Isolation ofT CellHybridomas. T cell hybridomas were produced by fusion of lymphoblasts from MBP-specific T cell lines to the murine TCR c~/fl-BWl100.129.237 cell line (15) . Wells positive for cell growth in HAT medium were tested for I1.,2 production (10Vwell) after stimulation with MBP (20/~g/ml) in the presence of irradiated LEW spleen cells (5 x 10S/well) and then subcloned at limiting dilution. All hybrids used in this study secreted Ib2 when stimulated with whole MBP or with the synthetic peptide MBP68-88.
Isolation of CD8-Con A Blasts. Vf18.2 + MBP 68-88-reactive T cells are almost exclusively CD4+; thus, for control purposes it was necessary to prepare a population of Con A-activated T cells enriched in CD4 from which a Vf18.2 cDNA library could be generated and sequenced. A panning method (16) was used to deplete lymph node cells of the CD8 + subpopulation. Cells (2-3 x 107) were incubated on ice for 1 h in saturating amounts of supernatants of post-log phase growth cultures of the OX8 hybridoma (anti-rat CD8) (17) . The ceils were washed three times in HBSS (Fisher Scientific Co. Allied Corp., Pittsburgh, PA), resuspended in 3 ml HBSS containing 2% FCS 0.R. Scientific, Woodland, CA), and then placed on petri dishes which had been coated overnight at 4~ with 10 ml goat anti-mouse Ig (10 ~g/ml; Fisher Scientific Co. Allied Corp.). Dishes were returned to 4~ for 1 h and nonadherent cells were removed by gentle pipetting. These nonadherent cells were panned a second time on anti-Ig coated dishes. Nonadherent ceils recovered with this protocol contained <5% contaminating cells of the CD8 + subset. Recovered cells were cultured at 2 x 10S/ml in RPMI 1640 containing 10% FCS, 5 x 10 -s M 2-ME, 2 mM glutamine, 100 /~g/ml penicillin/streptomycin, and 5/~g/ml Con A. T cell blasts were harvested after 48 h.
Determination of TCR Vfl Utilization. TCR Vfl utilization was determined by PCR amplification ofcDNA as described previously (18) . RNA was isolated from various cell populations after lysis in guanidinium isothiocyanate and phenol extraction (19) or centrifugation through a cesium chloride cushion (20) . cDNA was prepared from 5-10 #g total RNA in Taq polymerase buffer (50 mM KC1, 10 mM Trls-HC1 pH8.3, 2.5 mM MgCI2, 0.01% gelatin) in a 50/~1 reaction volume containing 40 mM 2-ME, 0.5 mM dNTPs (Pharmacia Fine Chemicals, piscataway, NJ), 20 U RNA guard (Pharmacia Fine Chemicals), 15 U AMV reverse transcriptase (Pharmacia Fine Chemicals), and 1 /~M Cfl-specific oligonucleotide primer. This primer, 5'CATAGAAtTcCACTIGGCAGCGGAAGT-GGT3' (Genosys, The Woodlands, TX), anneals to both rat TCR Cfll and Cfl2 mRNA. Bases in small letters denote changes in the TCR Cfl sequence made to create an EcoRI restriction endonuclease site. The cDNA was then amplified in 1.5 mM MgC12 Taq buffer in the presence of 1/~M Cfl oligonucleotide, 1/~M of a 5' consensus Vfl8 oligonucleotide primer (Vf18-5'), 5'GGGCCGC-GGAACACATGGAAGCTGCAGTCAC3' (containing a 5'-SaclI restriction endonuclease site), 200/~M each dNTP (Pharmacia Fine Chemicals), and 2 U Taq DNA polymerase (Pharmacia Fine Chemicals). Samples were overlaid with mineral oil, heated for 5 min at 940C to denature DNA/RNA duplexes, and then subjected to 30 amplification cycles of I min at 94~ 1.5 min at 550C, and 2 min at 72~ in a thermal cycler (Perkin-Elmer Corp., Norwalk, CT). After amplification, the samples were extracted with chloroform to remove mineral oil, precipitated with ethanol, and digested with SaclI plus EcoRI (New England Biolabs, Beverly, MA). The resulting DNA was separated on a 1.4% agarose gel. The appropriate size product was isolated using Prep-A-Gene (Bio-Rad Laboratories, Richmond, CA) and ligated into the ScalI/EcoRI site of pBluescript II (Stratagene Inc., La Jolla, CA). The ligation mixture was transformed into the bacterial strain DH5. Multiple ampicillin-resistant colonies were selected and miniprep DNA was prepared by standard methods (21). The plasmid DNA was then sequenced directly by the dideoxy chain termination method (22) using the Sequenase sequencing method (U.S. Biochemical, Cleveland, OH).
Results

V~ Utilization in EAE T Cells.
cDNA samples from 15 different MBP 68-88-reactive T cell clones and hybridomas derived from MBP/CFA immunized LEW rats were ampl/fied using a V~8 consensus primer (V~8-5'). Sequence analyses of the PCR products indicated that all of the MBP-reactive T cells used the VB8.2 gene segment.
CDR3 Sequences in EAE T Cells. Table 1 summarizes the details of our comparison of CDR3 sequences of LEW V/38.2 + TCR T cell clones and hybridomas (Table 2) , along with several independent Vfl8.2 + PCR isolates from MBP/CFA-immune lymph nodes (Table 3) , with the CDR3 sequences from LEW V138.2 + TCR from CD8-Con A blasts (Table 4) and CFA-immunized lymph nodes (Table 5) . CD8-blasts were used as control material because V~8.2 + T cells reactive to MBP 68-88 are exclusively CD4 + . The clones and hybridomas were derived from rats immunized with intact MBP, and all were shown to be reactive in cub ture to the encephalitogenic peptide MBP 68-88. Lymph node isolates were derived from MBP-irnmunized animals, but their reactivity with respect to MBP 68-88 is not known.
There are two main findings with respect to this comparison. First, of isolates from 15 different MBP peptide-reactive T cell clones and hybridomas, most (12) Utilization of different J/3 dements proved to be ordy somewhat limited among the MBP 68-88-reactive T cell clones and hybridomas (Table 1 ). There appears to be a disproportionate usage ofJ/32.7. The remaining use J131.1, 1.3, 1.4, and 2.5. In comparison, JB utilization among control populations of VB8.2 + Con A blasts and CFA immune lymph nodes is more extensive, although here too, JB2.7 appears to be used disproportionately with V/38.2.
Post EAE T Cells. Finally, we sequenced the TCR from three different MBP 68-88-reactive T cell clones derived from LEW rats that had recovered from paralytic EAE. These three clones also utilized V/38.2 +, but only one of them uses AspSer in CDR3 (Table 6 ). The two AspSer-clones, BB12 and A2, were found to be encephalitogenic in adoptive transfer protocols (14) . J~2.7 * 25 vf18.2 isolates from lymph nodes of two MBP-immune rats were assessed; these nine contained AspSer. * These two isolates were derived from different animals.
Discussion
Several studies have focused attention on one interesting feature of EAE in experimental animal models: the limited usage of TCR Vc~ and V~ segments in immune responses to encephalitogenic fragments of myelin basic protein (7, 8, 12, (23) (24) (25) . The T cell response of B10.PL/J mice to MBP 1-9 is dominated by VB2V~8.2 and Vo~4VB8.2 (7) but PL/J mice use Vc~4V~8.2 (8) . SJL mice use VB4 and VB17 predominantly in response to MBP 81-98 (24, 25) . Despite the fact that it is a different species, uses different MHC molecules for presenting antigen, and responds to a different encephalitogenic fragment (MBP 68-88), the T cell response of LEW rats in EAE, like that of B10.PL and PL/J mice, is also heavily dominated by Vc~2 and VBS.2 (12, 23, this report). The implications of this finding are not clear.
We report here that the CDR3 of V~8.2 + MBP-immune T cells is also highly conserved in LEW rats with respect to some elements and shows somewhat limited usage with respect to others. Of 15 different PCR isolates from VB8.2 § T cell clones and hybridomas, all with demonstrable reactivity to MBP 68-88, 12 use AspSer in the first two amino acid positions of CDR3 and two others use ThrSer (Table Gold et al. 2). Many (5/15) of these use Jf12.7 (Table 2 ) and a majority (8/15) use only a single N nucleotide addition (Fig. 1 ). This contrasts with Vf18.2 + control T cells from Con A blasts (Table 4) and CFA-immune lymph nodes (Table 5) , where none of 31 CDR3 sequences use AspSer or ThrSer. Jfl utilization is more extensive in this control material, although here too, Jf12.7 seems to have a disproportionate association (11/31) with VflS.2. N region nucleotide addition among control VBS.2 + T cells is also more extensive, only 1 of 31 with a single nucleotide addition and the majority showing four to nine N region additions (Fig. 1) . Dominant presence of AspSer in the CDR3 region is also seen in material from MBP-immune lymph nodes. Here, 9/25 VB8.2 § isolates use AspSer, but none of 16 Vf18.2 + isolates from CFA-immune nodes use AspSer (Table 5 , Fig. 1 ). It should be noted that three previously reported CDR3 sequences associated with VflS.2 in EAE were AspSer + (12, 23) .
It may be important to point out in these considerations that even the limited number of N region additions we have indicated for MBP 68-88-reactive T cells (Fig. 1) for two reasons may be an overestimate. First, in the absence of known 10 -Cy sA1 a S e r S e r S e rMe tAs pLeuMe t G1 uG1 n -t gt gccagcagt agt a t gga t c t t a tg gagcag 11 -Cy sA1 a S e r S e r As pG1 yG1 yG1 y G1 uG1 n -tgtgccagcagt gacggtggggga gagcag 12 -Cy sAl a S e r Th r P r oTh rG1 yA1 a G1 uGl n -tgtgccagc ag accgac tggggc t gagcag 13 -Cy sAl a S e r S e r A1 aGl yP r o Ty rGl uGl n -tgtgccagcagt gcgggt ccc t a tgagcag 14 -Cy sA1 a S e r S e r Gl uA1 aAs pTr pGl yG1 y Ty rGluGl n -t gt gccagcagt gaggc t gac tgggggggc t a t gagcag 15 -Cy sA1 a S e r Ar gP r oG1 yTh r P r o Ty rGl uG1 n -t gt gccagcag acccgggac t ccc t a tgagcag (Tables 4 and 5 ). Conserved/3 chain junctional region sequences have also been described previously in murine T cell responses to antigen, but each of these studies indicates an interesting difference with the rat model described here, where Vf18.2 chains use AspSer in the first positions of CDR3, a minimal number of N region additions, and extensive representation of JB elements.
(a) In the B10.PL mouse, EAE model Vf18.2 + T cells reactive to the encephalitogenic sequence MBP 1-9 express distinct amino acid sequences in the fl chain junctional region (7, 8) , but these conserved DB regions are always associated with a particular J~ element, whereas in the rat, AspSer sequences are common to the CDR3 region of the fl chain regardless of the J/~ element used.
(b) The response of I-Ed-restricted T cell clones to the 110-121 fragment of sperm whale myoglobin is highly homogeneous, being dominated by V/38.2 + T cells (10) , but here the whole fl chain CDR3 junctional region, consisting of D~2.1 and J~2.6, is also conserved.
(c) In B10.A mice, specificity for cytochrome c requires either Asn or Asp in the first position of CDR3/~. In this case this amino acid is associated with two different J/~ elements and a considerable degree of diversity in the (N)D/~(N) region (6). Similar findings have been reported for TCR responses to ~, repressor protein (9) . A second interesting feature of EAE, particularly in the LEW rat, is that this is usually a monophasic, self-limiting autoimmune disease. Rats become paralyzed 12-16 d after immunization with MBP, and then recover. Recovered rats are refractory to subsequent attempts to induce active EAE, and this resistance appears to be mediated by regulatory T cells with antireceptor specificity for V~8.2 + disease-causing T cells. Whether recovery from paralytic EAE and subsequent resistance to further disease induction is a reflection of limited TCR utilization in MBP responses is not yet clear, but it is a critical issue in considerations of immunotherapeutic approaches to at least some forms of autoimmune disease.
Considerable support exists for an antireceptor regulatory T cell population in recovery from and induced resistance to EAE in LEW rats. First, V~8.2 + disease-causing T cells reactive to MBP 68-88 can be used in attenuated form or in subclinical numbers as vaccines to induce resistance (31); T cells from recovered animals can transfer resistance to secondary recipients (32) ; and T cells from resistant animals have been shown to have lytic specificity for disease-causing T cell populations (33) . In this respect the EAE resistance model in rats resembles closely a model of specifically induced resistance to GVH in F1 rats after immunization with diseasecausing T cells of parental strain origin (34) . Second, TCR peptides encompassing part of the CDR2 region of V/38.2 are effective vaccines for inducing resistance to EAE (35) , and they are also therapeutically effective in reducing the severity of ongoing disease (36) . This demonstrates that an immune response directed to a particular portion of TCR molecules highly conserved in a particular disease-causing T cell population can inhibit the function of cells bearing these receptors.
If regulatory T cells with antireceptor specificity are a significant factor in recovery and resistance to autoimmune disease in the EAE model, an important question to be considered concerns the identity of the idiotypic target structure. Logic dictates that this target structure be conserved, as it is common to most if not all of the disease-causing T cells. Some portion of the VBS.2 sequence, and, from the V B 8 . 2 --C y s A 1 a S e r S e r --t g t g c c a g c a g t A2 -C y s A 1 a S e r -t g t g c c a g c E --C y s A 1 a S e r S e r --t g t g c c a g c a g t G l y T h r G l y g g g a c a g g g A r g A r g G l y G l y G l y S e r a g g a g a g g g g g g g g g t c a
A s p S e r g a c a g c T h r A s p L y s J~2.3 a c a g a t a a g G l u T h r J~2.5 g a g a c c c S e r T y r G l u G l n JB2.7 t c c t a t g a g c a g findings in this paper, a portion of the CDK3 expressing AspSer sequences, are obvious candidates. In this context, it is of interest that T cells reactive to MBP 68-88 are difficult to find in recovered animals (14) , and AspSer sequences in the CDK3, which almost completely dominate Vf18.2 T cells present during active disease (12/15; Table 1 ), appear in only one of three VB8.2-positive, MBP 68-88-reactive T cell clones obtained from animals that have recovered from EAE (Table  5 ). This finding is consistent with the possibility that recovery from disease depends upon immune elimination or inactivation of Vf18.2 + AspSer + T cells. It is also of interest that of the two clones from recovered animals lacking AspSer in CDK3, one of these (BB12) contained a CDR3 region devoid of N region nucleotide additions.
Previous findings that a Vf18.2 CDR2 region peptide (35) , as well as a CDR3 peptide (37), of TCR used in the MBP response are effective vaccines for EAE raise the possibility that a natural target idiotype may be encompassed in these TCR regions. However, definitive proof for this would require the demonstration that T cells obtained from animals recovering from EAE are reactive to these TCK peptides and that these peptide-reactive T cells confer disease protection in secondary recipients. Finally, it should be noted that this issue may be more complex. Previously one of us (D. Sun) has noted that donotypic regulation of the encephalitogenic response may also exist (33) .
